Immunonutrition for modifying inflammatory markers and improving clinical outcomes following traumatic brain injury: a systematic review and meta-analysis
Abstract
BACKGROUND: Traumatic brain injury (TBI) induces a severe hypermetabolic state with elevated energy expenditure and progressive systemic inflammation. Nutritional optimization in this setting is challenging, particularly in severe TBI (Glasgow Coma Scale [GCS] = 3–8). Its clinical role in these hospitalized TBI patients remains unclear. This systematic review and meta-analysis aimed to evaluate the impact of immunonutrition on neuroinflammation and neurosurgical outcomes in TBI patients, with a focus on omega-3 fatty acids, arginine, and glutamine. METHODS: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, we systematically reviewed the available evidence from PubMed, Scopus, and Web of Science. The inclusion criteria focused on severely hospitalized TBI patients with a GCS score of 3 to 8 who were receiving immunonutrition components. The quality and certainty of the evidence were assessed using the Cochrane Risk of Bias tool and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, respectively. RESULTS: A total of 12 studies were eligible and included in our comprehensive full-text review. However, only 5 articles were included in the meta-analysis. Systematic review findings indicated that immunonutrition was associated with reductions in inflammatory markers, decreased rates of nosocomial infections, and improvements in CO₂ reactivity, blood–brain barrier integrity, and cerebral…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.